Nature子刊 | 背靠背！杨茂君团队阐述红斑狼疮靶点复合物SLC15A4-TASL的分子机制与药物研发工作
Heinz, L.X., Lee, J., Kapoor, U., Kartnig, F., Sedlyarov, V., Papakostas, K., Cesar-Razquin, A., Essletzbichler, P., Goldmann, U., Stefanovic, A., et al. (2020). TASL is the SLC15A4-associated adaptor for IRF5 activation by TLR7-9. Nature 581, 316-322. Teruel, M., and Alarcon-Riquelme, M.E. (2016). The genetic basis of systemic lupus erythematosus: What are the risk factors and what have we learned. J Autoimmun 74, 161-175. Moulton, V.R., Suarez-Fueyo, A., Meidan, E., Li, H., Mizui, M., and Tsokos, G.C. (2017). Pathogenesis of Human Systemic Lupus Erythematosus: A Cellular Perspective. Trends Mol Med 23, 615-635. Chen, X., Xie, M., Zhang, S., Tortajada, M., Yin, J., Liu, C., et al. (2023). Structural basis for recruitment of TASL by SLC15A4 in human endolysosomal TLR signaling Nature Communications 14. Boeszoermenyi, A., Bernaleau, L., Chen, X., Kartnig, F., Xie, M., Zhang, H., Zhang, S., Delacrétaz, M., Koren, A., Hopp, A.-K., et al. (2023). A conformation-locking inhibitor of SLC15A4 with TASL proteostatic anti-inflammatory activity. Nature Communications 14.
—END—
内容为【iNature】公众号原创，
转载请写明来源于【iNature】